These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 1548245)

  • 21. Trichotillomania and body dysmorphic disorder.
    Tanquary J
    J Clin Psychiatry; 1994 Jan; 55(1):35-6. PubMed ID: 8294391
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug treatment for Alzheimer's disease.
    Tom T; Cummings JL
    West J Med; 1998 Apr; 168(4):264. PubMed ID: 9584667
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
    Beier MT
    Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Jumex in the treatment of Alzheimer's disease].
    Zarajczyk M
    Neurol Neurochir Pol; 1999; 33 Suppl 1():73-5. PubMed ID: 10404523
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of donepezil on Alzheimer's disease: the relationship between cognitive function and rapid eye movement sleep.
    Mizuno S; Kameda A; Inagaki T; Horiguchi J
    Psychiatry Clin Neurosci; 2004 Dec; 58(6):660-5. PubMed ID: 15601392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selegiline versus oxiracetam in patients with Alzheimer-type dementia.
    Falsaperla A; Monici Preti PA; Oliani C
    Clin Ther; 1990; 12(5):376-84. PubMed ID: 2125242
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Buspirone augmentation of fluoxetine in patients with obsessive compulsive disorder.
    Jenike MA; Baer L; Buttolph L
    J Clin Psychiatry; 1991 Jan; 52(1):13-4. PubMed ID: 1988411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluoxetine versus trazodone in the treatment of outpatients with major depression.
    Debus JR; Rush AJ; Himmel C; Tyler D; Polatin P; Weissenburger J
    J Clin Psychiatry; 1988 Nov; 49(11):422-6. PubMed ID: 3053668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Possible trazodone potentiation of fluoxetine: a case series.
    Nierenberg AA; Cole JO; Glass L
    J Clin Psychiatry; 1992 Mar; 53(3):83-5. PubMed ID: 1548249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cholinesterase inhibitors in Alzheimer's disease].
    Ventura M; Sternon J
    J Pharm Belg; 2001; 56(3):62-8. PubMed ID: 11508260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacological basis of the beneficial effects of (-)deprenyl (selegiline) in Parkinson's and Alzheimer's diseases.
    Knoll J
    J Neural Transm Suppl; 1993; 40():69-91. PubMed ID: 8294902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent dystonia associated with buspirone.
    Boylan K
    Neurology; 1990 Dec; 40(12):1904. PubMed ID: 2247245
    [No Abstract]   [Full Text] [Related]  

  • 34. Medications to modify at-home behavior of Alzheimer's patients.
    Maletta GJ
    Geriatrics; 1985 Dec; 40(12):31-6, 39-40, 42. PubMed ID: 2866147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of melatonin in Alzheimer's disease.
    Cardinali DP; Brusco LI; Liberczuk C; Furio AM
    Neuro Endocrinol Lett; 2002 Apr; 23 Suppl 1():20-3. PubMed ID: 12019347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of Galantamine on sleep quality in Thai Alzheimer's disease patients.
    Chankrachang S; Senanarong V; Poungvarin N; Phanthumchinda K; Tavichachart N; Praditsuwan R; Nidhinandana S
    J Med Assoc Thai; 2008 Sep; 91(9):1343-9. PubMed ID: 18843862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacologic treatment of Alzheimer's disease: an update.
    DeLaGarza VW
    Am Fam Physician; 2003 Oct; 68(7):1365-72. PubMed ID: 14567491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current treatments for Alzheimer's disease: cholinesterase inhibitors.
    Doody RS
    J Clin Psychiatry; 2003; 64 Suppl 9():11-7. PubMed ID: 12934969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.
    Reisberg B; Borenstein J; Salob SP; Ferris SH; Franssen E; Georgotas A
    J Clin Psychiatry; 1987 May; 48 Suppl():9-15. PubMed ID: 3553166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.